bioAffinity Technologies closes $4 million financing

bioAffinity Technologies closed a previously announced registered direct offering and concurrent private placement that raised about $4 million before fees and expenses. The company said it plans to use the net proceeds for working capital, CyPath Lung sales support and general corporate purposes.